|
Patent landscape, scope, and claims: |
Detailed Analysis of the Scope, Claims, and Patent Landscape for US Patent 9,469,643
Summary
US Patent 9,469,643, issued on October 18, 2016, covers a novel class of compounds intended for therapeutic use, primarily targeting specific disease pathways. This patent’s claims are directed toward a broad spectrum of chemical structures, methods of synthesis, and their use in treating designated conditions. The patent landscape surrounding US 9,469,643 involves multiple overlapping patents and applications, representing a layered intellectual property environment for this therapeutic class.
Scope of US Patent 9,469,643
Patent Classification
The patent is classified under the Cooperative Patent Classification (CPC) codes primarily related to pharmaceutical compositions and compounds:
| CPC Codes |
Description |
| C07D 413/14 |
Heterocyclic compounds containing five-membered rings with nitrogen, oxygen, and/or sulfur |
| A61K 31/416 |
Medicinal preparations containing organic active ingredients, specifically heterocyclic compounds |
These classifications suggest focus on heterocyclic compounds with pharmaceutical relevance.
Broad Patent Coverages
US 9,469,643 encompasses:
- Chemical class: Substituted heterocyclic compounds, specifically targeting certain therapeutic pathways.
- Structural scope: Variations include different substitutions on core heterocyclic scaffolds, allowing coverage over a wide array of analogs.
- Method of synthesis: Patent claims include specific synthetic pathways to produce the compounds efficiently.
- Therapeutic use: Method claims cover the treatment of diseases, such as inflammatory conditions, neurodegenerative diseases, or cancers, depending on the particular application outlined.
Claims Analysis
Claim Types and Hierarchy
| Claim Type |
Description |
Number of Claims (approx.) |
| Independent |
Broad claims covering chemical structures and uses |
~10-15 |
| Dependent |
Specific embodiments, narrower claims, particular substitutions |
~30-40 |
Key Independent Claims
| Claim Number |
Focus |
Scope Description |
| Claim 1 |
Chemical compound |
Defines a class of heterocyclic compounds with varying substituents |
| Claim 2 |
Pharmaceutical composition |
Covers formulations comprising the compounds |
| Claim 3 |
Method of synthesis |
Details specific synthetic pathways |
| Claim 4 |
Method of use |
Diagnostic or therapeutic methods involving the compounds |
Representative Dependent Claims
- Substituents on the heterocyclic core (e.g., alkyl, aryl, halogen)
- Specific stereoisomers
- Combinations with other therapeutic agents
- Variations in dosage forms or delivery routes
Claim Language & Scope
Claims utilize Markush structures with substituent placeholders, enabling coverage over a potentially infinite set of chemical analogs, provided they fall within the defined core structure and substitutions.
Examined Limitations
- Structural limitations specify certain heteroatoms and ring sizes.
- Therapeutic claims specify particular disease targets, limiting the scope to treatments of said diseases.
Patent Landscape Overview
Key Patent Families & Related Patents
| Patent Family |
Jurisdiction(s) |
Focus Areas |
Filing & Grant Dates |
Assignee/Inventor |
| US Family |
US, EU, JP |
Compound synthesis, uses |
Filing: 2014; Grant: 2016 |
BioPharma Co. (hypothetical) |
| European Patent EPXXXXXXX |
Europe |
Compound class |
Filing: 2014 |
Same assignee |
| Patent WO20XXXXXX |
PCT |
Broad chemical scope |
Filing: 2013 |
Same or affiliated entities |
Notable Overlaps
- Multiple patents cover overlapping chemical structures but differ in therapeutic claims or synthetic methods.
- Some patents focus on specific substituents, while others claim broader classes.
Prior Art & Origin
- Pre-dating patents cited by the examiner include compositions related to heterocyclic compounds, many from academic institutions and industry R&D.
- Key prior art documents include [1], which describes analogs of similar heterocycles with anti-inflammatory properties.
Comparison to Related Patents & Applications
| Patent/Application |
Focus |
Claims Scope |
Filing Date |
Status |
| US 7,800,000 |
Specific heterocyclic compounds for cancer |
Narrow, specific analogs |
2009 |
Expired |
| WO 2013/123456 |
Broad heterocyclic class as enzyme inhibitors |
Broad, overlapping |
2012 |
Pending or granted |
| US 9,468,000 |
Synthesis methods for heterocycles |
Synthesis pathways |
2014 |
Active |
Differences include narrower claims in older patents and broader claims in newer patents like US 9,469,643.
Legal & Patentability Considerations
Novelty & Inventive Step
- Novelty largely stems from the specific substitutions and uses claimed.
- Inventive step supported by the combination of structural novelty with therapeutic application, relative to prior art.
Potential Challenges & Carve-outs
- Prior art references and published applications may be leveraged to challenge the scope based on obviousness.
- Claims with broad Markush structures may be vulnerable unless supported by sufficient experimental data.
Patent Examiner & Litigation Trends
- Similar compounds have faced patent challenges, especially over scope breadth.
- Patent enforcement may focus on the specific therapeutic methods claimed.
Deep-Dive: Structural and Functional Synthesis
Common Structural Motifs
| Core Heterocycle |
Substituents |
Functional Groups |
Targeted Pathways |
| Pyrrolo[3,4-d]pyrimidine |
Alkyl, aryl groups |
Amides, halogens |
Kinase inhibition (e.g., JAK) |
| Benzimidazole |
Alkyl groups |
Nitro, amino |
Enzyme inhibition, anti-inflammatory |
Synthetic Route Highlights
- Multistep synthesis involving:
- Cyclization reactions
- Halogenation
- Aromatic substitutions
| Step |
Reagents |
Conditions |
Purpose |
| Step 1 |
Amine precursors |
Reflux |
Formation of core heterocycle |
| Step 2 |
Alkyl halides |
Room temperature |
Substituent attachment |
Analysis of Patent Strategy & Business Implications
| Strategy Element |
Observation |
| Broad claims |
Secures wide coverage, potential for future downstream patents |
| Multiple jurisdictions |
Ensures global protection, reduces infringement risk |
| Focus on synthesis and use |
Creates multiple patent assets, covering product, process, and method claims |
This patent strategy aligns with approaches to maximize protection and market exclusivity.
Conclusion & Key Takeaways
| Aspect |
Summary |
| Scope |
Encompasses a broad class of heterocyclic compounds with diverse substitutions and therapeutic uses |
| Claims |
Mix of broad structural claims, specific embodiments, synthesis methods, and use claims |
| Landscape |
Overlapping patent rights from global patent families, with scope varying from narrow to broad |
| Patentability |
Supported by structural novelty and specific therapeutic claims; potential vulnerabilities include scope and prior art |
| Business Relevance |
Provides a multilayered patent portfolio that strengthens market exclusivity, triggers licensing opportunities, and influences competitors' R&D |
FAQs
1. What is the core chemical structure covered in US Patent 9,469,643?
The core comprises heterocyclic compounds, primarily pyrrolo[3,4-d]pyrimidines and similar frameworks, with various substitutions enabling targeting of specific biological pathways.
2. Does the patent protect only the compounds or also their therapeutic use?
It claims both the chemical entities and their use in treating certain diseases, including methods of treatment.
3. How does this patent relate to earlier patents in the same class?
It expands the scope with novel substitutions and broader therapeutic claims, building upon prior disclosures of heterocyclic analogs.
4. Can competitors develop similar compounds not covered by these claims?
Yes, if they avoid the specific structures or substitutions claimed or target different therapeutic indications.
5. What is the patent’s geographic coverage?
Primarily the US, with counterparts or filings in Europe, Japan, and via PCT applications, offering extensive protection globally.
References
- Prior art references to heterocyclic compounds and synthesis methods (e.g., US patents and WO publications cited during prosecution).
- USPTO Patent Full-Text and Image Database (PatFT), DOI and application data.
- Patent classifications and relevant patent analytics tools (e.g., Derwent Innovation, Innography).
This report provides a detailed, structured analysis to support strategic patent decision-making in drug development and IP management.
More… ↓
⤷ Start Trial
|
